Biotechnology & Pharmaceutical

Providing support to innovators driving medical advances.

As the life sciences industry experiences unprecedented rapid expansion, biotechnology, medical device, and pharmaceutical companies need strategic partners that understand the research, development, and commercialization of their products and services.

Perkins Coie is privileged to work with a diverse range of companies, both public and private, that focus on therapeutics (including biologics, biosimilars, and small molecules), prophylactics, diagnostics, and related services in the life sciences industry.

Our team of more than 80 biotechnology and pharmaceuticals lawyers, patent agents, and science advisers understands the inherent challenges of our clients' missions to develop and commercialize innovative products and services to diagnose, prevent, and treat disease, as well as the regulations that govern these pursuits.

Our legal team spans corporate, technology transactions, intellectual property (IP), and litigation practices and is dedicated to helping biotechnology and pharmaceutical companies—regardless of their size or lifecycle stage—address the complex legal matters that arise during development and commercialization.

Areas of Experience

Business Counsel to Biotechnology, Medical Device & Pharmaceutical Clients

Perkins Coie’s business lawyers work with emerging and established life sciences companies in the United States and abroad in a variety of areas, including:

Choice of entity, corporate formation and structure, corporate governance, and public reporting
Raising capital, including venture capital, private/preferred stock investments, debt financings, initial public offerings, and subsequent equity follow-on financings
Due diligence, mergers, and acquisitions
Corporate partnering, complex licensing, strategic alliances, technology agreements, research and development collaborations, joint ventures, and supply and distribution agreements
Business model counseling, IP strategy, and the U.S. Food and Drug Administration approval process
Executive compensation and equity incentive arrangements
Real estate and land use matters

Patent Prosecution & Litigation

Many of our team members hold degrees in molecular biology, chemistry, or biophysics and bring with them diverse experiences from both the life sciences industry. We offer comprehensive services to biotechnology, medical device, and pharmaceutical enterprises in the following areas:

Patent portfolio management and patent procurement
Opinions on patentability, patent infringement, validity, freedom to operate, and design-around issues
Patent litigation to enforce rights or defend against infringement claims
Post-grant proceedings under the America Invents Act, including inter partes review, reexaminations, and reissues
International Trade Commission Chapter 337 actions

Industry & Technical Strengths

Our commitment to our clients has enabled us to become experts in a wide range of emergent technologies. This experience translates to the creation of high-quality patents and the development of strategic patent portfolios that align with our clients' business objectives. Our areas of focus include:

Artificial intelligence and machine learning diagnostic tools, drug discovery, and related health services
Antibody, peptibody, and ADC therapeutics and diagnostics
Biologics and biosimilars
Cellular therapeutics
Diagnostics
Drug discovery, development, and formulation
Gene editing, including CRISPR technology
Gene therapy, including nonviral and viral gene delivery
Genetic testing, including cfDNA diagnostics and NIPT
Genetically engineered cells and microorganisms
Immunology, including autoimmune treatment and diagnostics
Immunotherapy, including CAR-T and TCR therapy
Microfluidics, microplates, and microarrays
Nanotechnology
Nucleic acid sequencing and multiplex screening
NexGen sequencing
Oncology
Peptide design and therapeutics
Protein identification, characterization, and therapeutics
Personalized medicine/precision medicine
Pharmaceuticals
Small molecule identification, synthesis, and therapeutics
Stem cell generation, modification, and therapy
Targeted drug delivery
Viral diagnostics, therapeutics, and vaccines, including for COVID-19

Recognition

联系方式

浏览相关专业人员信息

Mark R. Wicker

Partner

MWicker@perkinscoie.com

Notice

Before proceeding, please note: If you are not a current client of Perkins Coie, please do not include any information in this e-mail that you or someone else considers to be of a confidential or secret nature. Perkins Coie has no duty to keep confidential any of the information you provide. Neither the transmission nor receipt of your information is considered a request for legal advice, securing or retaining a lawyer. An attorney-client relationship with Perkins Coie or any lawyer at Perkins Coie is not established until and unless Perkins Coie agrees to such a relationship as memorialized in a separate writing.

858.720.5733